Current advances in therapies for calcium pyrophosphate crystal arthritis
- 1 March 2016
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Rheumatology
- Vol. 28 (2), 140-144
- https://doi.org/10.1097/bor.0000000000000252
Abstract
Calcium pyrophosphate (CPP) crystal disease is a common rheumatologic disorder that has received limited attention from the scientific community. This review is aimed at summarizing current evidence for managing CPP disease (CPPD), focusing on recently reported advances.New data from case series indicate that interleukin-1β inhibitors can help patients with refractory forms of CPPD. Methotrexate, formerly a promising agent, failed to demonstrate benefits in a recent trial, but still merits consideration for some patients. No significant advances on crystal dissolution have been achieved to date. Proper characterization of the CPP crystal disease picture is needed, ruling out the possible coexistence of another persistent arthritis unrelated to the CPP deposition.Advances on CPP crystal dissolution and establishing definitions of the clinical spectrum of CPPD remain the main challenges for CPP crystal disease management.Keywords
This publication has 28 references indexed in Scilit:
- Nonpharmacologic and Pharmacologic Management of CPP Crystal Arthritis and BCP Arthropathy and Periarticular SyndromesRheumatic Disease Clinics of North America, 2014
- Diagnosis and Clinical Manifestations of Calcium Pyrophosphate and Basic Calcium Phosphate Crystal Deposition DiseasesRheumatic Disease Clinics of North America, 2014
- Prevalence of calcium pyrophosphate and monosodium urate crystals in synovial fluid of patients with previously diagnosed joint diseasesJoint Bone Spine, 2013
- The detection of calcium pyrophosphate crystals in the synovial fluid of patients with rheumatoid arthritis using the cytospin technique: prevalence and clinical correlationRheumatology International, 2012
- An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition diseaseRheumatology, 2009
- Update in calcium deposition diseasesCurrent Opinion in Rheumatology, 2007
- Comparison of characteristics of patients with and without calcium pyrophosphate dihydrate crystal deposition disease who underwent total knee replacement surgery for osteoarthritisOsteoarthritis and Cartilage, 2007
- UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyteAnnals Of The Rheumatic Diseases, 2003
- Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studiesOsteoarthritis and Cartilage, 2003
- SYNOVIAL FLUID CALCIUM PYROPHOSPHATE DIHYDRATE CRYSTALS AND ALIZARAN RED POSITIVITY: ANALYSIS OF 3000 SAMPLESRheumatology, 1990